Syndax Pharmaceuticals Inc (SNDX)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current SNDX market cap is 1.56B. The company's latest EPS is USD -2.4603 and P/E is -7.43.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 3.5M |
| Operating Income | -49.68M | -56.36M | -77.91M | -79.51M | -74.22M |
| Net Income | -44.62M | -51.15M | -72.47M | -72.4M | -68.06M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.52M | 1.52M | 139.71M | 0 | 0 |
| Operating Income | -57.54M | -71.42M | 26.22M | -151.76M | -229.95M |
| Net Income | -56.05M | -73.16M | 24.93M | -149.34M | -209.36M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 431.34M | 399.22M | 612.88M | 543.03M | 476.95M |
| Total Liabilities | 31.3M | 40.04M | 58.68M | 51.14M | 42.61M |
| Total Equity | 400.04M | 359.19M | 554.2M | 491.89M | 434.34M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 63.53M | 300.61M | 449.66M | 497.24M | 612.88M |
| Total Liabilities | 31.93M | 48.43M | 41.29M | 29.79M | 58.68M |
| Total Equity | 31.6M | 252.19M | 408.37M | 467.45M | 554.2M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -74.6M | -119.25M | -160.6M | -83.55M | -155.19M |
| Investing | 93.82M | 133.9M | 117.61M | -99.4M | -37.65M |
| Financing | 3.8M | 5.65M | 264.13M | 2.17M | 2.84M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -50.61M | -71.26M | 29.13M | -133.68M | -160.6M |
| Investing | 12.78M | -142.53M | -40.87M | -186.19M | 117.61M |
| Financing | 28.57M | 304.42M | 118.46M | 172.25M | 264.13M |
| Market Cap | 1.56B |
| Price to Earnings Ratio | -7.43 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 5.27 |
| Price to Book Ratio | 2.81 |
| Dividend Yield | - |
| Shares Outstanding | 85.1M |
| Average Volume (1 week) | 1.45M |
| Average Volume (1 Month) | 1.15M |
| 52 Week Change | 15.04% |
| 52 Week High | 25.34 |
| 52 Week Low | 11.215 |
| Spread (Intraday) | 1.3 (6.91%) |
| Company Name | Syndax Pharmaceuticals Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.syndax.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
